\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ ongoing\\.\ \(5\)\
\-\ image\\ \\#1\\:\ \(0\)\
\-\ left\\ renal\\ upper\\ polar\\ heterogeneous\\ increased\\ uptake\\,\\ with\\ enlarged\\ area\\ of\\ heterogenous\\ photopenia\\ at\\ the\\ inter\\-\\ to\\ lower\\ pole\\.\\ intense\\ multifocal\\ uptake\\ in\\ the\\ anterior\\ mandible\\ likely\\ represents\\ prior\\ dental\\ work\\ vs\\.\\ periodontal\\ disease\\.\ \(0\)\
\-\ image\\ \\#2\\:\ \(0\)\
\-\ same\\ findings\\,\\ spot\\ view\\.\ \(0\)\
\-\ image\\ \\#3\\ and\\ \\#4\\:\ \(0\)\
\-\ large\\ heterogeneous\\ soft\\ tissue\\ mass\\ infiltrating\\ the\\ left\\ inter\\-\\ and\\ lower\\ renal\\ pole\\ extending\\ to\\ the\\ abdominal\\ wall\\ and\\ invading\\ renal\\ pelvic\\ structures\\ and\\ demonstrating\\ mild\\ heterogeneous\\ contrast\\ enhancement\\.\ \(0\)\
\-\ renal\\ cell\\ carcinoma\ \(60\)\
\-\ renal\\ cell\\ carcinoma\ \(60\)\
\-\ metastasis\\ to\\ the\\ kidney\ \(0\)\
\-\ 54\\ year\\ old\\ female\\ with\\ one\\ month\\ history\\ of\\ left\\ greater\\ than\\ right\\ back\\ pain\\.\ \(1\)\
\-\ tc\\-99m\\ mdp\\ is\\ a\\ commonly\\ employed\\ skeletal\\ radiopharmaceutical\\.\\ diphosphonate\\ labeled\\ tc\\-99m\\ rapidly\\ disperses\\ throughout\\ the\\ extracellular\\ space\\ and\\ accumulates\\ in\\ regions\\ of\\ increased\\ osteogenic\\ \\/\\ osteoblastic\\ activity\\ and\\ regions\\ of\\ increased\\ blood\\ flow\\.\\ adequate\\ bone\\ uptake\\ and\\ target\\ to\\ background\\ ratio\\ for\\ skeletal\\ imaging\\ is\\ generally\\ obtained\\ 2\\-3\\ hours\\ after\\ injection\\.\\ tc\\-99m\\ mdp\\ is\\ primarily\\ renally\\ cleared\\ through\\ glomerular\\ filtration\\.\\ a\\ simple\\ planar\\ gamma\\ scintillation\\ camera\\ windowed\\ around\\ tc\\-99m\\â\\€\\™s\\ characteristic\\ 140\\ kev\\ decay\\ is\\ used\\ to\\ obtain\\ planar\\ whole\\ body\\ and\\ spot\\ views\\.\\ spect\\ can\\ be\\ added\\ if\\ further\\ lesion\\ localization\\ is\\ required\\.\\ \ \(0\)\
\-\ in\\ a\\ normal\\ whole\\ body\\ bone\\ scan\\,\\ activity\\ is\\ greatest\\ in\\ the\\ axial\\ skeleton\\ and\\ relatively\\ lower\\ in\\ the\\ appendicular\\ skeleton\\.\\ the\\ kidneys\\ should\\ always\\ be\\ visualized\\ and\\ be\\ less\\ intense\\ than\\ the\\ lumbar\\ spine\\.\\ \ \(0\)\
\-\ asymmetry\\ or\\ irregularity\\ of\\ the\\ kidneys\\ should\\ always\\ spur\\ further\\ evaluation\\.\\ frequently\\ ultrasound\\ or\\ ct\\ are\\ chosen\\ based\\ on\\ the\\ clinical\\ circumstances\\,\\ risk\\ factors\\,\\ and\\ suspicions\\.\\ in\\ this\\ case\\ the\\ patient\\ received\\ a\\ contrast\\ enhanced\\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\.\\ \ \(0\)\
\-\ renal\\ cell\\ carcinoma\\ \\(rcc\\)\\ presents\\ most\\ commonly\\ with\\ hematuria\\,\\ flank\\ pain\\,\\ palpable\\ mass\\,\\ and\\ weight\\ loss\\.\\ risk\\ factors\\ include\\ tobacco\\ use\\,\\ family\\ history\\,\\ and\\ chronic\\ dialysis\\ among\\ others\\.\\ on\\ ct\\,\\ heterogeneous\\ contrast\\ enhancement\\ and\\ varying\\ degrees\\ of\\ hemorrhage\\ and\\ necrosis\\ are\\ apparent\\.\\ ten\\ percent\\ calcify\\ and\\ a\\ few\\ percent\\ demonstrate\\ cystic\\ regions\\.\\ on\\ ultrasound\\,\\ rcc\\ is\\ most\\ frequently\\ hyperechoic\\ but\\ can\\ be\\ hypoechoic\\ up\\ to\\ 30\\%\\ of\\ the\\ time\\.\\ stage\\ i\\ disease\\ is\\ confined\\ to\\ the\\ kidney\\,\\ stage\\ ii\\ is\\ confined\\ to\\ gerota\\â\\€\\™s\\ fascia\\,\\ stage\\ iii\\ demonstrates\\ venous\\ invasion\\ \\(a\\)\\ or\\ lymph\\ node\\ metastasis\\ \\(b\\)\\ or\\ both\\ \\(c\\)\\,\\ and\\ stage\\ iv\\ demonstrates\\ direct\\ extension\\ into\\ adjacent\\ organs\\ and\\/or\\ distant\\ organ\\ metastasis\\.\\ \ \(0\)\
\-\ treatment\\ may\\ include\\ radical\\ nephrectomy\\,\\ chemotherapy\\,\\ or\\ radiotherapy\\ \\(for\\ palliation\\)\\.\\ at\\ the\\ time\\ of\\ this\\ evaluation\\,\\ this\\ patient\\ was\\ still\\ undergoing\\ evaluation\\ for\\ treatment\\.\\ however\\ based\\ on\\ the\\ images\\ provided\\,\\ there\\ is\\ extrarenal\\ involvement\\ without\\ venous\\ invasion\\ or\\ nodal\\ metastasis\\ placing\\ this\\ patient\\â\\€\\™s\\ disease\\ at\\ least\\ at\\ stage\\ ii\\ \\(50\\%\\ 5\\-year\\ survival\\)\\.\\ \\ \ \(0\)\
\-\ this\\ is\\ a\\ good\\ example\\ of\\ how\\ a\\ nuclear\\ medicine\\ tc\\-99m\\ bone\\ scan\\ used\\ in\\ search\\ of\\ spinal\\ disease\\ can\\ stimulate\\ the\\ discovery\\ of\\ a\\ primary\\ malignancy\\ \\(likely\\ accounting\\ for\\ this\\ patient\\â\\€\\™s\\ symptoms\\)\\ and\\ prompt\\ appropriate\\ treatment\\.\\ any\\ renal\\ asymmetry\\,\\ whether\\ in\\ size\\,\\ shape\\ or\\ degree\\ of\\ uptake\\ on\\ tc\\-99m\\ bone\\ scan\\ must\\ not\\ be\\ overlooked\\ and\\ should\\ always\\ prompt\\ further\\ clinical\\ and\\/or\\ imaging\\ evaluation\\.\\ \ \(0\)\
\-\ while\\ renal\\ assymetry\\ on\\ tc\\-99m\\ bone\\ scan\\ can\\ prompt\\ the\\ discovery\\ of\\ primary\\ renal\\ cell\\ carcinoma\\,\\ it\\ is\\ not\\ a\\ suggested\\ means\\ of\\ evaluating\\ for\\ renal\\ cell\\ metastasis\\.\\ bone\\ scan\\ evaluation\\ for\\ metastasis\\ is\\ ideal\\ for\\ osteoblastic\\ rather\\ than\\ osteolytic\\ \\(rcc\\)\\ lesions\\.\\ while\\ some\\ osteolytic\\ lesions\\ are\\ noted\\ on\\ bone\\ scan\\,\\ sensitivity\\ is\\ in\\ the\\ neighborhood\\ of\\ 50\\%\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ thrall\\ jh\\,\\ ziessman\\ ha\\.\\ nuclear\\ medicine\\,\\ the\\ requisites\\,\\ 2nd\\ edition\\.\\ mosby\\ 2001\\.\ \(0\)\
\-\ weissleder\\ r\\,\\ wittenberg\\ j\\,\\ harisinghani\\ mg\\.\\ primer\\ of\\ diagnostic\\ imaing\\,\\ 3rd\\ edition\\.\\ mosby\\ 2003\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.22832525243134708\ \(0\)\
\-\ and\\:\\ 0\\.16668162787371366\ \(0\)\
\-\ metastasis\\:\\ 0\\.1612377831726686\ \(0\)\
\-\ the\\:\\ 0\\.16095327828807585\ \(0\)\
\-\ stage\\:\\ 0\\.14599200934583775\ \(0\)\
\-\ is\\:\\ 0\\.140574623382736\ \(0\)\
\-\ bone\\:\\ 0\\.14004015533847636\ \(0\)\
\-\ scan\\:\\ 0\\.13051873178028237\ \(0\)\
\-\ rcc\\:\\ 0\\.1296693814274336\ \(0\)\
\-\ of\\:\\ 0\\.12197906433137172\ \(0\)\
\-\ prompt\\:\\ 0\\.11964474280081708\ \(0\)\
\-\ or\\:\\ 0\\.11479687944772562\ \(0\)\
\-\ uptake\\:\\ 0\\.11277389383599408\ \(0\)\
\-\ evaluation\\:\\ 0\\.1118028179693538\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.10615014098549505\ \(0\)\
\-\ cell\\:\\ 0\\.1048712358235128\ \(0\)\
\-\ always\\:\\ 0\\.10383482160199582\ \(0\)\
\-\ regions\\:\\ 0\\.09440238251579104\ \(0\)\
\-\ discovery\\:\\ 0\\.08976069380056095\ \(0\)\
\-\ carcinoma\\:\\ 0\\.08772612731342792\ \(0\)\
\-\ osteolytic\\:\\ 0\\.08587481889194724\ \(0\)\
\-\ mdp\\:\\ 0\\.08429874401759449\ \(0\)\
\-\ planar\\:\\ 0\\.08245915696645452\ \(0\)\
\-\ in\\:\\ 0\\.08209025497519017\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.08203763790381496\ \(0\)\
\-\ skeleton\\:\\ 0\\.0797631618672114\ \(0\)\
\-\ confined\\:\\ 0\\.07844352427633292\ \(0\)\
\-\ asymmetry\\:\\ 0\\.07783125715083855\ \(0\)\
\-\ edition\\:\\ 0\\.07783125715083855\ \(0\)\
\-\ for\\:\\ 0\\.07779082063046044\ \(0\)\
\-\ on\\:\\ 0\\.07751487294715781\ \(0\)\
\-\ whole\\:\\ 0\\.07696428737129427\ \(0\)\
\-\ can\\:\\ 0\\.07696317462944309\ \(0\)\
\-\ mosby\\:\\ 0\\.07615211124171077\ \(0\)\
\-\ this\\:\\ 0\\.0755931669288608\ \(0\)\
\-\ be\\:\\ 0\\.07436825440834748\ \(0\)\
\-\ to\\:\\ 0\\.07333004586738992\ \(0\)\
\-\ percent\\:\\ 0\\.07251966206006391\ \(0\)\
\-\ should\\:\\ 0\\.07177233939803364\ \(0\)\
\-\ further\\:\\ 0\\.07164219647800263\ \(0\)\
\-\ spot\\:\\ 0\\.0715669907655288\ \(0\)\
\-\ image\\:\\ 0\\.07034644182807592\ \(0\)\
\-\ nuclear\\:\\ 0\\.0693771704885975\ \(0\)\
\-\ intense\\:\\ 0\\.06922321440133056\ \(0\)\
\-\ skeletal\\:\\ 0\\.06647768097628855\ \(0\)\
\-\ invasion\\:\\ 0\\.06541074066592506\ \(0\)\
\-\ medicine\\:\\ 0\\.06463809392514858\ \(0\)\
\-\ pole\\:\\ 0\\.06390926509763174\ \(0\)\
\-\ kidneys\\:\\ 0\\.06312397184364986\ \(0\)\
\-\ than\\:\\ 0\\.062353567131586164\ \(0\)\
\-\ factors\\:\\ 0\\.06202925291998195\ \(0\)\
\-\ disease\\:\\ 0\\.06156318008468028\ \(0\)\
\-\ frequently\\:\\ 0\\.06038943044974918\ \(0\)\
\-\ increased\\:\\ 0\\.0594805702028732\ \(0\)\
\-\ disperses\\:\\ 0\\.05863581438318343\ \(0\)\
\-\ renally\\:\\ 0\\.05863581438318343\ \(0\)\
\-\ windowed\\:\\ 0\\.05863581438318343\ \(0\)\
\-\ neighborhood\\:\\ 0\\.05863581438318343\ \(0\)\
\-\ ii\\:\\ 0\\.057816772437526205\ \(0\)\
\-\ lower\\:\\ 0\\.0562080419661037\ \(0\)\
\-\ accumulates\\:\\ 0\\.056029650982645514\ \(0\)\
\-\ wittenberg\\:\\ 0\\.056029650982645514\ \(0\)\
\-\ at\\:\\ 0\\.055395808572335004\ \(0\)\
\-\ used\\:\\ 0\\.05489790812179611\ \(0\)\
\-\ commonly\\:\\ 0\\.054261140487694974\ \(0\)\
\-\ filtration\\:\\ 0\\.05418054862285695\ \(0\)\
\-\ decay\\:\\ 0\\.05418054862285695\ \(0\)\
\-\ suspicions\\:\\ 0\\.05418054862285695\ \(0\)\
\-\ harisinghani\\:\\ 0\\.05418054862285695\ \(0\)\
\-\ activity\\:\\ 0\\.053838079944193006\ \(0\)\
\-\ contrast\\:\\ 0\\.053444778040381564\ \(0\)\
\-\ based\\:\\ 0\\.05311872139932898\ \(0\)\
\-\ kev\\:\\ 0\\.052746273404418155\ \(0\)\
\-\ ideal\\:\\ 0\\.052746273404418155\ \(0\)\
\-\ treatment\\:\\ 0\\.05239689948804154\ \(0\)\
\-\ risk\\:\\ 0\\.05239609132446937\ \(0\)\
\-\ venous\\:\\ 0\\.05235482265455974\ \(0\)\
\-\ glomerular\\:\\ 0\\.05157438522231903\ \(0\)\
\-\ scintillation\\:\\ 0\\.05157438522231903\ \(0\)\
\-\ assymetry\\:\\ 0\\.05157438522231903\ \(0\)\
\-\ weissleder\\:\\ 0\\.05157438522231903\ \(0\)\
\-\ imaing\\:\\ 0\\.05157438522231903\ \(0\)\
\-\ kidney\\:\\ 0\\.05151744522375377\ \(0\)\
\-\ 50\\:\\ 0\\.0512122634224038\ \(0\)\
\-\ periodontal\\:\\ 0\\.050583567882182656\ \(0\)\
\-\ primer\\:\\ 0\\.050583567882182656\ \(0\)\
\-\ polar\\:\\ 0\\.04972528286253047\ \(0\)\
\-\ photopenia\\:\\ 0\\.04972528286253047\ \(0\)\
\-\ extracellular\\:\\ 0\\.04972528286253047\ \(0\)\
\-\ extrarenal\\:\\ 0\\.04972528286253047\ \(0\)\
\-\ spur\\:\\ 0\\.04896822182178111\ \(0\)\
\-\ palliation\\:\\ 0\\.04896822182178111\ \(0\)\
\-\ ziessman\\:\\ 0\\.04896822182178111\ \(0\)\
\-\ circumstances\\:\\ 0\\.04829100764409167\ \(0\)\
\-\ gerota\\:\\ 0\\.04829100764409167\ \(0\)\
\-\ stimulate\\:\\ 0\\.04829100764409167\ \(0\)\
\-\ body\\:\\ 0\\.048261042735107486\ \(0\)\
\-\ patient\\:\\ 0\\.047701540138780946\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.047678392902804345\ \(0\)\
\-\ camera\\:\\ 0\\.047678392902804345\ \(0\)\
\-\ thrall\\:\\ 0\\.047678392902804345\ \(0\)\
\-\ while\\:\\ 0\\.047392118835374517\ \(0\)\
\-\ overlooked\\:\\ 0\\.04711911946199254\ \(0\)\
\-\ clinical\\:\\ 0\\.046473501016743655\ \(0\)\
\-\ cleared\\:\\ 0\\.04612830212185617\ \(0\)\
\-\ chosen\\:\\ 0\\.04612830212185617\ \(0\)\
\-\ osteogenic\\:\\ 0\\.04568484424355374\ \(0\)\
\-\ placing\\:\\ 0\\.04568484424355374\ \(0\)\
\-\ jh\\:\\ 0\\.04568484424355374\ \(0\)\
\-\ ultrasound\\:\\ 0\\.04523168878839661\ \(0\)\
\-\ primary\\:\\ 0\\.045090421656494656\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.04451295606145462\ \(0\)\
\-\ added\\:\\ 0\\.04451295606145462\ \(0\)\
\-\ calcify\\:\\ 0\\.044165434140515894\ \(0\)\
\-\ employed\\:\\ 0\\.043835741883765184\ \(0\)\
\-\ ten\\:\\ 0\\.043835741883765184\ \(0\)\
\-\ likely\\:\\ 0\\.04382056715640466\ \(0\)\
\-\ include\\:\\ 0\\.04363105247642056\ \(0\)\
\-\ accounting\\:\\ 0\\.04352213872131824\ \(0\)\
\-\ time\\:\\ 0\\.04346490890839303\ \(0\)\
\-\ labeled\\:\\ 0\\.04293740944597362\ \(0\)\
\-\ appendicular\\:\\ 0\\.04293740944597362\ \(0\)\
\-\ invading\\:\\ 0\\.04266385370166606\ \(0\)\
\-\ fascia\\:\\ 0\\.04266385370166606\ \(0\)\
\-\ ha\\:\\ 0\\.04266385370166606\ \(0\)\
\-\ nodal\\:\\ 0\\.04240146666532638\ \(0\)\
\-\ enhancement\\:\\ 0\\.04220782951463106\ \(0\)\
\-\ lesions\\:\\ 0\\.04211460807902056\ \(0\)\
\-\ spect\\:\\ 0\\.0419067926609167\ \(0\)\
\-\ localization\\:\\ 0\\.0419067926609167\ \(0\)\
\-\ ct\\:\\ 0\\.041876484446679005\ \(0\)\
\-\ are\\:\\ 0\\.04173845401151446\ \(0\)\
\-\ requisites\\:\\ 0\\.041673036361529685\ \(0\)\
\-\ background\\:\\ 0\\.04122957848322726\ \(0\)\
\-\ obtain\\:\\ 0\\.04101881895190748\ \(0\)\
\-\ means\\:\\ 0\\.04101881895190748\ \(0\)\
\-\ ongoing\\:\\ 0\\.0408147513418775\ \(0\)\
\-\ dental\\:\\ 0\\.04061696374193994\ \(0\)\
\-\ dialysis\\:\\ 0\\.04061696374193994\ \(0\)\
\-\ radical\\:\\ 0\\.04061696374193994\ \(0\)\
\-\ 140\\:\\ 0\\.040238761143090884\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.03971016838018941\ \(0\)\
\-\ gamma\\:\\ 0\\.03954320860825932\ \(0\)\
\-\ tobacco\\:\\ 0\\.038915628575419275\ \(0\)\
\-\ mandible\\:\\ 0\\.038767861382151374\ \(0\)\
\-\ among\\:\\ 0\\.038767861382151374\ \(0\)\
\-\ how\\:\\ 0\\.038767861382151374\ \(0\)\
\-\ others\\:\\ 0\\.038623415082689336\ \(0\)\
\-\ imaging\\:\\ 0\\.038537723559545094\ \(0\)\
\-\ varying\\:\\ 0\\.03848214368564713\ \(0\)\
\-\ distant\\:\\ 0\\.03834391061993934\ \(0\)\
\-\ search\\:\\ 0\\.03820858794133958\ \(0\)\
\-\ most\\:\\ 0\\.0381634762665374\ \(0\)\
\-\ target\\:\\ 0\\.0379462009049999\ \(0\)\
\-\ organs\\:\\ 0\\.03781891773941607\ \(0\)\
\-\ organ\\:\\ 0\\.037694106248470756\ \(0\)\
\-\ left\\:\\ 0\\.03752201177897427\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.03745152690059022\ \(0\)\
\-\ sensitivity\\:\\ 0\\.0372177706012032\ \(0\)\
\-\ evaluating\\:\\ 0\\.036882341985465535\ \(0\)\
\-\ demonstrates\\:\\ 0\\.036840507109881564\ \(0\)\
\-\ ratio\\:\\ 0\\.03677431272290078\ \(0\)\
\-\ rapidly\\:\\ 0\\.03666806914997614\ \(0\)\
\-\ greatest\\:\\ 0\\.03666806914997614\ \(0\)\
\-\ example\\:\\ 0\\.03656355319158099\ \(0\)\
\-\ infiltrating\\:\\ 0\\.03596981537962751\ \(0\)\
\-\ whether\\:\\ 0\\.03587598028510921\ \(0\)\
\-\ survival\\:\\ 0\\.0357834953827644\ \(0\)\
\-\ adequate\\:\\ 0\\.03569232236731429\ \(0\)\
\-\ multifocal\\:\\ 0\\.035602424540801654\ \(0\)\
\-\ irregularity\\:\\ 0\\.03551376672390379\ \(0\)\
\-\ primarily\\:\\ 0\\.035170880641477074\ \(0\)\
\-\ shape\\:\\ 0\\.034766496377839975\ \(0\)\
\-\ heterogenous\\:\\ 0\\.03453554016118871\ \(0\)\
\-\ 54\\:\\ 0\\.03453554016118871\ \(0\)\
\-\ suggested\\:\\ 0\\.03431259562182489\ \(0\)\
\-\ degrees\\:\\ 0\\.03423996671552378\ \(0\)\
\-\ least\\:\\ 0\\.033888644859612856\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.033753322181013096\ \(0\)\
\-\ 2nd\\:\\ 0\\.033555534581075526\ \(0\)\
\-\ 3rd\\:\\ 0\\.03349093514467342\ \(0\)\
\-\ undergoing\\:\\ 0\\.03330094328834555\ \(0\)\
\-\ simple\\:\\ 0\\.03317733198222648\ \(0\)\
\-\ 2003\\:\\ 0\\.03299626114026373\ \(0\)\
\-\ represents\\:\\ 0\\.03276250484087671\ \(0\)\
\-\ still\\:\\ 0\\.032481779447394915\ \(0\)\
\-\ rather\\:\\ 0\\.032481779447394915\ \(0\)\
\-\ hematuria\\:\\ 0\\.032427076225139045\ \(0\)\
\-\ direct\\:\\ 0\\.03231904696257429\ \(0\)\
\-\ appropriate\\:\\ 0\\.03221280338964966\ \(0\)\
\-\ flank\\:\\ 0\\.03216033297730205\ \(0\)\
\-\ degree\\:\\ 0\\.03205665992623462\ \(0\)\
\-\ mg\\:\\ 0\\.032005443800127355\ \(0\)\
\-\ injection\\:\\ 0\\.03190421982122454\ \(0\)\
\-\ received\\:\\ 0\\.03190421982122454\ \(0\)\
\-\ iii\\:\\ 0\\.03165792187918862\ \(0\)\
\-\ node\\:\\ 0\\.03151454961930102\ \(0\)\
\-\ must\\:\\ 0\\.03142071452478273\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.03132822962243791\ \(0\)\
\-\ few\\:\\ 0\\.0311026770125095\ \(0\)\
\-\ generally\\:\\ 0\\.03105850096357731\ \(0\)\
\-\ apparent\\:\\ 0\\.03067401221281571\ \(0\)\
\-\ demonstrating\\:\\ 0\\.030233319483972263\ \(0\)\
\-\ provided\\:\\ 0\\.030080274400862226\ \(0\)\
\-\ work\\:\\ 0\\.029893954403999116\ \(0\)\
\-\ relatively\\:\\ 0\\.02985732986149841\ \(0\)\
\-\ good\\:\\ 0\\.02982091282460112\ \(0\)\
\-\ characteristic\\:\\ 0\\.029641859747469974\ \(0\)\
\-\ lumbar\\:\\ 0\\.029606639989111734\ \(0\)\
\-\ around\\:\\ 0\\.02926466626861958\ \(0\)\
\-\ references\\:\\ 0\\.02923144867624808\ \(0\)\
\-\ same\\:\\ 0\\.029003611513312398\ \(0\)\
\-\ not\\:\\ 0\\.028949185229191758\ \(0\)\
\-\ views\\:\\ 0\\.028939971490274004\ \(0\)\
\-\ family\\:\\ 0\\.028845677528019056\ \(0\)\
\-\ pelvic\\:\\ 0\\.028661140743767827\ \(0\)\
\-\ visualized\\:\\ 0\\.028630893206449883\ \(0\)\
\-\ lymph\\:\\ 0\\.02851130669058021\ \(0\)\
\-\ use\\:\\ 0\\.028054040880397767\ \(0\)\
\-\ necrosis\\:\\ 0\\.02802651368706843\ \(0\)\
\-\ history\\:\\ 0\\.028016542782597957\ \(0\)\
\-\ mass\\:\\ 0\\.028010340042001602\ \(0\)\
\-\ vs\\:\\ 0\\.027971810464812563\ \(0\)\
\-\ hours\\:\\ 0\\.027944632454686803\ \(0\)\
\-\ diagnostic\\:\\ 0\\.027944632454686803\ \(0\)\
\-\ enhanced\\:\\ 0\\.027917568878626724\ \(0\)\
\-\ structures\\:\\ 0\\.027550178039800872\ \(0\)\
\-\ malignancy\\:\\ 0\\.027448954060898055\ \(0\)\
\-\ greater\\:\\ 0\\.02701219507827053\ \(0\)\
\-\ throughout\\:\\ 0\\.02696544876445624\ \(0\)\
\-\ view\\:\\ 0\\.026850049079131074\ \(0\)\
\-\ involvement\\:\\ 0\\.026537535246373763\ \(0\)\
\-\ pain\\:\\ 0\\.026240395229451083\ \(0\)\
\-\ iv\\:\\ 0\\.026198045662234683\ \(0\)\
\-\ required\\:\\ 0\\.02617741132727987\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.026034796510895696\ \(0\)\
\-\ spinal\\:\\ 0\\.026034796510895696\ \(0\)\
\-\ extension\\:\\ 0\\.025954700897286454\ \(0\)\
\-\ obtained\\:\\ 0\\.025934831979399324\ \(0\)\
\-\ palpable\\:\\ 0\\.025758722611876884\ \(0\)\
\-\ pelvis\\:\\ 0\\.02564394117209812\ \(0\)\
\-\ weight\\:\\ 0\\.025568543359528115\ \(0\)\
\-\ 30\\:\\ 0\\.025012393899248416\ \(0\)\
\-\ enlarged\\:\\ 0\\.02499523076537021\ \(0\)\
\-\ less\\:\\ 0\\.02494401463926295\ \(0\)\
\-\ extending\\:\\ 0\\.02485955100836596\ \(0\)\
\-\ size\\:\\ 0\\.024826073902385306\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.02454834575298592\ \(0\)\
\-\ back\\:\\ 0\\.02445312045843662\ \(0\)\
\-\ flow\\:\\ 0\\.024421689638748204\ \(0\)\
\-\ space\\:\\ 0\\.024406031677732608\ \(0\)\
\-\ spine\\:\\ 0\\.024221052298210526\ \(0\)\
\-\ adjacent\\:\\ 0\\.023766460886221186\ \(0\)\
\-\ area\\:\\ 0\\.02375231876870469\ \(0\)\
\-\ any\\:\\ 0\\.023696059417687258\ \(0\)\
\-\ some\\:\\ 0\\.023069456444941558\ \(0\)\
\-\ year\\:\\ 0\\.022599053956433815\ \(0\)\
\-\ abdomen\\:\\ 0\\.022371949938421967\ \(0\)\
\-\ loss\\:\\ 0\\.02233785123872502\ \(0\)\
\-\ wall\\:\\ 0\\.022303932480233237\ \(0\)\
\-\ month\\:\\ 0\\.022303932480233237\ \(0\)\
\-\ cystic\\:\\ 0\\.022082269486047277\ \(0\)\
\-\ through\\:\\ 0\\.021825986110035743\ \(0\)\
\-\ chronic\\:\\ 0\\.021763480692162742\ \(0\)\
\-\ however\\:\\ 0\\.021701577261983306\ \(0\)\
\-\ with\\:\\ 0\\.02153857884586654\ \(0\)\
\-\ if\\:\\ 0\\.0213034568515504\ \(0\)\
\-\ blood\\:\\ 0\\.021293813054064966\ \(0\)\
\-\ axial\\:\\ 0\\.021179202175247294\ \(0\)\
\-\ one\\:\\ 0\\.02099261171953336\ \(0\)\
\-\ mild\\:\\ 0\\.020784522377195386\ \(0\)\
\-\ prior\\:\\ 0\\.020514305929777345\ \(0\)\
\-\ anterior\\:\\ 0\\.020471767125813358\ \(0\)\
\-\ both\\:\\ 0\\.020446378324594068\ \(0\)\
\-\ symptoms\\:\\ 0\\.020061181218413767\ \(0\)\
\-\ abdominal\\:\\ 0\\.020053231199072166\ \(0\)\
\-\ upper\\:\\ 0\\.01959337437484563\ \(0\)\
\-\ soft\\:\\ 0\\.019519831354937314\ \(0\)\
\-\ into\\:\\ 0\\.019490648150124704\ \(0\)\
\-\ noted\\:\\ 0\\.01943989421610553\ \(0\)\
\-\ without\\:\\ 0\\.019339573051983076\ \(0\)\
\-\ tissue\\:\\ 0\\.0192337957363448\ \(0\)\
\-\ demonstrate\\:\\ 0\\.019061278944159595\ \(0\)\
\-\ it\\:\\ 0\\.018768460245476733\ \(0\)\
\-\ may\\:\\ 0\\.01845114063897236\ \(0\)\
\-\ case\\:\\ 0\\.018420253554940782\ \(0\)\
\-\ large\\:\\ 0\\.018371140881852835\ \(0\)\
\-\ up\\:\\ 0\\.018136947762334606\ \(0\)\
\-\ but\\:\\ 0\\.01813105359427529\ \(0\)\
\-\ findings\\:\\ 0\\.018095801642192332\ \(0\)\
\-\ after\\:\\ 0\\.017786943427608812\ \(0\)\
\-\ female\\:\\ 0\\.017692703682597864\ \(0\)\
\-\ presents\\:\\ 0\\.017637907188586967\ \(0\)\
\-\ lesion\\:\\ 0\\.017578165746257805\ \(0\)\
\-\ images\\:\\ 0\\.01696014739824763\ \(0\)\
\-\ normal\\:\\ 0\\.014970200638681241\ \(0\)\
\-\ there\\:\\ 0\\.01458901346533269\ \(0\)\
\-\ was\\:\\ 0\\.01277822389423339\ \(0\)\
\-\ right\\:\\ 0\\.01215606766121224\ \(0\)\
\-\ old\\:\\ 0\\.010851457327419996\ \(0\)\
